← Leaderboards
Joseph R Holtman
Yaupon Therapeutics, Inc.
$1,444,902
Attributed
$1,444,902
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $570K · FY2006–08$1M$750K$500K$250K$0
'06
'07
'08
Funding mix
By agency
NIH$1,444,902 · 5
By mechanism
R42$1,093,974 · 1
R41$272,935 · 2
M01$77,993 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Morphine”
- Abhik Das · Research Triangle Institute$25,628,714
- Jeffrey Reich · Sparian Biosciences, Inc.$21,990,518
- Sabita Roy · University Of Minnesota Twin Cities$20,925,755
- Sandra D. Comer · New York State Psychiatric Institute$18,481,203
- Ying-Xian Pan · Sloan-Kettering Institute For Cancer Res$18,192,035
- Shilpa J Buch · University Of Kansas Medical Center$17,492,222
Research focus
MorphineChronic PainPainDoseOpioidAnalgesicsMotorMedicalMotor ActivityAdverse EffectsConceptDiabetic NeuropathiesHyperalgesiaInjuryBiological AvailabilityFundingComplex Regional Pain SyndromesEnantiomerClassClinical Trials, Phase IChronic Cancer PainChronic Neuropathic PainDrug KineticsGrant
Grant awards (7)
Norketamine for Treatment of Pain$215,604
R42 · FY2008 · DA · contact PI
Norketamine for Treatment of Pain$369,203
R42 · FY2007 · DA · contact PI
Nornicotine for Treatment of Pain$172,935
R41 · FY2007 · DA · contact PI
DIFFERENCES IN OPIOID-INDUCED HYPERALGESIA AND ANALGESIA$27,840
M01 · FY2007 · RR · contact PI
Norketamine for Treatment of Pain$509,167
R42 · FY2006 · DA · contact PI
DIFFERENCES IN OPIOID-INDUCED HYPERALGESIA AND ANALGESIA$50,153
M01 · FY2006 · RR · contact PI
Norketamine for Treatment of Pain$100,000
R41 · FY2003 · DA